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The symptoms and histopathology of many virus diseases depend not so much on 
damage  to  cells  by  virus  but  on  the  immunobiological  reaction  to  the  infection. 
Nowhere is this more clearly illustrated than with murine lymphocytic choriomenin- 
gitis (LCM) 1 virus (1). The basic features of the system were established by Traub in 
the 1930's (2): mice that received virus transplacentally or shortly after birth developed 
a  life-long peristent  infection,  whereas  the  outcome in  mice infected  as adults  was 
quite different.  In the latter case peripheral  injection  usually produced  an abortive 
immunizing infection, whereas intracerebral  (i.c.)  injection resulted in choriomenin- 
gitis and death within 7-9 d. 
The immunological basis for this choriomeningitis has been investigated intensely 
during the last  10 yr. The early observations of Rowe (3) showing lack of correlation 
between serum antibody level and immunity, followed by the finding that thymec- 
tomized mice could not be killed by i.c. infection (4), were the first indications  of the 
central  role of thymus-derived lymphocytes in  fatal  lymphocytic  choriomeningitis. 
Following the pioneering work of Volkert  (5), Gilden et al.  (6)  established a  model 
system  for adoptive  transfer  of lymphocytes into  adult  i.c.-infected  mice.  In  these 
elegant studies, Cole and co-workers (7)  demonstrated, by selective reconstitution of 
the  immune  system  of  cyclophosphamide  (CY)-spared  mice,  that  only  immune 
lymphocytes bearing  thymus-derived antigens  caused  rapid  convulsive death.  Fur- 
thermore, Johnson and colleagues (8) conclusively demonstrated that B cells and their 
secreted  products  played  no  role  in  pathogenesis  by showing  that  mice  markedly 
depleted  of immunoglobulin  (Ig)-bearing lymphocytes were just  as  susceptible  as 
normal mice to LCM-induced central nervous system (CNS) disease. 
For  several  years  we  have  focused  our  attention  on  the  mechanisms  of LCM- 
induced acute CNS disease by studying LCM strains lacking the ability to kill adult 
i.c.-infected mice in the classic convulsive manner (9,  10). One question asked was: do 
these so-called "docile" virus strains induce virus-specific T  cell responses, and if so, 
are these responses qualitatively or quantitatively different from those induced by the 
well-studied  so-called  "aggressive"  strains?  It  was  first  necessary  to  assess  T  cell 
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function  in  vitro  since  an  in  vivo response,  if made,  was obviously masked.  Using 
51Cr-labeled  LCM-infected  L  cells,  the  cytotoxic T  lymphocyte (CTL)  activity was 
found to be about  the same in mice infected with either type of virus  (11). CTL are 
widely considered to be the equivalent of the T  cell population responsible for murine 
LCM pathogenesis  (12-14). In view of our results one could conceivably question the 
equivalence of CTL with killer T  cells. It seemed more reasonable, however, to search 
for a reason why the CTL induced by infection with docile virus were not lethal. This 
paper shows that the CTL response induced by docile virus can be lethal, but only in 
mice in which the virus infection has not spread extensively beyond the site of entry. 
Materials  and Methods 
Viruses and Titrations.  Aggressive and docile viruses  were cloned from the blood of an adult 
ICR mouse infected at  birth with  tissue-culture-passed  LCM virus strain  UBC  (9). Viruses 
were quantitated  by plaque assay using the previously described  (15) Madin  Darby  canine 
kidney  (MDCK)  monolayer technique.  Virus content  of organs was determined  as  follows. 
Mice were killed by cervical dislocation. The brain, liver, kidneys, lungs, spleen, and heart were 
removed immediately under aseptic conditions. Organs were washed, weighed, ground with 
sterile sand with a  mortar and  pestle,  and resuspended  in tissue  culture medium.  After the 
samples were centrifuged at low speed, the supernatants were stored at -70°C until titrated by 
plaque assay. 
Reagents.  CY monohydrate was purchased from Sigma Chemical Company (St. Louis, MO) 
and  diluted  in  phosphate-buffered  saline  immediately  before  use.  Antimouse T  cell  serum 
(rabbit antimouse brain-associated Thy-I antiserum) was a product of Cedarlane Laboratories, 
Hornby, Ontario, Canada. 
Recipients for Adoptive Immunization.  3-wk-old female C3HeB/FeJ(H-2k)  or 4-wk-old female 
BALB/cByJ(H-2d) mice, from The Jackson Laboratory, Bar Harbor, ME, were infected i.c. 
usually with 300 (unless  stated otherwise) plaque-forming units (PFU) of virus in a volume of 
0.03 ml. Either 2 or 3 d later mice infected with the aggressive LCM substrain were given CY 
intraperitoneally at a dose of 150 mg/kg. In some experiments, mice infected with docile virus 
were also given CY. 
Donor Mice and Cell Preparation  for Adoptive Transfer.  The C3H or BALB/c mice were injected 
i.c. with 300 PFU of either virus substrain. On the 7th d after infection spleens were removed, 
and lymphocytes were prepared by standard procedures (11) involving separation on a cushion 
of sodium ditrizoate-Fieoll.  For adoptive transfer cells were resuspended  in Eagle's minimal 
essential medium and  10% heat-inactivated fetal calf serum. Each recipient mouse was given, 
via the retrobulbar venous plexus, 3-7 ×  107 cells (~1.5 mouse equivalents) in a volume of 0.2- 
0.4  ml.  In  some  adoptive  transfers  lymphocyte  populations  were  depleted  of T  cells  by 
incubation with Thy-1 antiserum and complement (11). 
Results 
Discordance  of  Plaque-forming  Titer  with  Murine  Lethality  as  a  Function  of  Virus 
Strain.  Table  I  shows  the  mortality  pattern  in  mice  injected  i.c.  with  increasing 
concentrations  of virus.  The  aggressive  strain  exhibited  a  phenomenon  frequently 
observed  (!6-19)  but  until  now not satisfactorily explained:  whereas  low doses  (30- 
1,800 PFU) invariably killed the mice, high doses (10  s- 108) spared them. On the other 
hand, a  large proportion of mice infected with docile virus were spared when injected 
with  a  dose  (300-3,000  PFU)  that  would  have  invariably  been  lethal  had  it  been 
aggressive virus. Virtually all mice surviving injection with docile virus were persist- 
ently infected at the end of 28-d observation periods. An i.c. dose of 300 PFU of either 
substrain was chosen for use in most of our studies. 
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TABLE  I 
Relationship between Virus Dose and Mortality Pattern in Mice Infected with 
Different Substrains of LCM Virus 
Number  Percent  Mean day of 
Virus strain  Dose  of mice  mortality  death (range)* 
Aggressive 
PFU/mouse 
3  6  16  12 
30  6  100  10.0 (9-11) 
300  52  I00  9.7 (8-12) 
1,800  14  100  8.9 (8-9) 
10s-106  16  0  -- 
Docile  0.01  6  0  -- 
0.3  8  75  14.2 (9-23) 
3  19  42  12.6 (9-16) 
30  15  53  17.0 (11-23) 
300  79  14  19.6 (10-17) 
3,000  20  25  18.6 (16-23) 
Data above were compiled based on injection of groups of no less than six 
C3H mice with a specific virus solution. Mice were counted daily and spun 
by the tail beginning on day 5 to detect a  convulsive  behavior as early as 
possible. 
* The experiments were terminated 28 d after infection. 
TABLE  II 
Disease Patterns in CY-treated Mice Injected with Aggressive and Docile Substrains of LCM Virus 
LCM-like 
Virus strain  Mouse strain  Day of CY  Percent  Mean day of death  convulsive 
treatment  mortality*  (range)  death 
--  C3H  0  0 (14)  --  -- 
Aggressive  C3H  --  100 (5)  9.4 (9-10)  + 
C3H  2  100 (7)  12.0 (l 1-14)  - 
C3H  3  84 (44)  18.4 (l 1-23)  - 
BALB/c  --  100 (12)  8.7 (8-9)  + 
BALB/c  3  55 (11)  13.0 (11-14)  - 
Docile  C3H  --  0 (5)  -- 
C3H  2  100 (7)  14.4 (14-16) 
C3H  3  48 (25)  17.3 (9-27) 
BALB/c  --  83 (12)  13.8 (13-18) 
BALB/c  3  80 (10)  12.6 (10-18) 
q 
C3H  and  BALB/c  mice were  injected i.c.  with  300  PFU  of either aggressive  or  docile virus.  The 
experiment was terminated 28 d after infection. Data were compiled based on injection of no less than 
five recipient mice per group. 
* Parenthesis indicate number of mice killed. 
over a  decade to  prevent lethal choriomeningitis in  adult  i.c.-infected mice  (6).  CY 
was given on the 2nd or 3rd day after infection (for reasons given below), and  in all 
cases such  treatment  not  only delayed death  but  also  prevented  neurologic disease 
(Table II).  Unexpectedly, a  low survival rate was found among  these mice. This has 
been encountered previously (14, 20), and because, until now, aggressive viruses were 
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response  against  the  infection.  However,  this  explanation  seems  unlikely  because 
toxicity was  apparent  in  GY-treated C3H  mice infected with  docile virus, whereas 
docile virus infection alone was usually not lethal (Table II). Lowering the standard 
dose of CY  (150 mg/kg)  in three 5-mg/kg decrements failed to either lower toxicity 
or  prevent  CNS  disease  (data  not  presented).  Docile virus was  found  to  be  more 
pathogenic  in  BALB/c  than  C3H  mice  (Table  II).  Differences  in  susceptibility to 
LCM  viruses among mouse strains have been repeatedly observed (17, 21). 
Adoptive  Transfer of CATS Disease and Identification of the Effector  Cell Population.  In 
preparation for four-way adoptive transfer experiments, the basic system was estab- 
lished using the  traditional  donor-recipient  mouse  combination  in  which  both  are 
infected with  aggressive virus.  The  data  in  the  upper  half of Table  III show  that 
adoptive transfer ofsyngeneic but not allogeneic splenocytes into CY-treated recipients 
resulted  in  convulsive  death  within  6  d.  A  5-6-d  interval  after  cell  transfer  for 
development  of  lethal  CNS  disease  has  been  reported  previously  (6,  20).  After 
treatment of the donor cells with antibody specific for the Thy-1 antigen, their ability 
to transfer CNS  disease was  lost. These mice died in a  nonconvulsive manner  14 d 
after CY treatment  (Table III). This was quite close to the mean day of death  (15.4, 
see Table II)  caused by the toxicity of CY  in control mice infected with  aggressive 
virus.  The  allogeneic  BALB/c  recipients  also  died  in  a  nonconvulsive  manner  at 
about the same time as the C3H recipients adoptively transferred with T  cell-depleted 
sple/aocytes. Again, this was most likely due to CY toxicity. 
Disease Outcome and the Timing of Adoptive Transfer in CY-treated Recipients.  Because of 
TABLE III 
Restrictions in Adoptive Transfer of CNS Disease in C3H Mice 
Virus strain*  Day of CY 
injected into  treatment/  Percent  Days to  LCM-like 
day of  mortality~:  death in re-  convulsive 
Donor  Recipient  adoptive  cipient mice  death 
mice  mice  transfer 
A  A  3/7  89 (61)  5.8  + 
A  A  2/4  I00 (6)  5.8  + 
A§  A  3/7  100 (10)  10.2  - 
A  All  3/7  50 (7)  11.0  - 
D  A  3/7  45 (11)¶  9.8  - 
D  A  2/4  100 (8)  6.2  + 
A  D  3/7  65 (26)  9.4  - 
A  D  2/4  100 (6)  5.3  + 
Donor and recipient  mice were injected i.c. with 300 PFU of either aggressive or 
docile virus. On the 7th d post-infection, splenocytes were purified from C3H mice 
and injected into syngeneic, and in one experiment allogeneic, CY-treated recipients, 
which had been infected 4 or 7 d earlier. As in the previous tables, the mean day of 
death was used to determine the number of days to death after adoptive transfer. 
Data were compiled based on the injection of no less than five recipient mice. 
* A, aggressive; D, docile. 
Parenthesis indicate number of mice. 
§ Donor splenocytes treated with Thy- 1 antiserum and complement before use. 
11 BALB/c mice used instead of C3H mice. 
¶ The outcome of two experiments.  In the third experiment,  all 10 mice died in a 
convulsive manner 4.8 d (mean) after adoptive transfer. PFAU ET AL.  83 
the toxicity of CY we encountered, it was decided to shorten the interval between CY 
treatment and adoptive transfer. In the first series of experiments recipient mice were 
infected, treated with CY on day 3, and then injected with donor lymphocytes on day 
7.  In  the second series,  the  infected donor mice were given CY  on day  2  and  the 
adoptive transfer on  the  4th  d.  The protocols produced strikingly different results 
(lower half of Table III). When adoptive transfers took place in recipients infected 7 
d previously, the only adoptive transfer combination that caused CNS disease in the 
majority of recipient mice was the classic one, i.e., when both donors and recipients 
were infected with aggressive virus. On the other hand, in each case when adoptive 
transfers were carried out with recipient mice infected 4  d  previously, CNS  disease 
developed ~6 d  later. The latter results strengthened our assumption that the docile 
virus-induced CTL represented a  population  of lymphocytes with  in  vivo activity 
(11).  Because each adoptive transfer of some 5  ×  107 lymphocytes contained -105 
PFU of virus, it became important to determine what effect intravenous (i.v.) injection 
of docile or aggressive virus alone would have on the mice. Over 20 mice were infected 
i.v.  with  105  PFU  of either  aggressive  or  docile  virus,  and  all  survived  a  28-d 
observation period. In fact, this result was obtained when a  group of mice injected 
with  aggressive virus was  also injected simultaneously with  a  normally lethal  dose 
(300 PFU) of the same virus by the i.e. route. Furthermore, lymphocyte populations 
treated with anti-Thy- 1 serum retained their initial virus infectivity, while losing their 
ability to transfer CNS disease (Table III). 
CNS Disease  in Mice Infected with Docile  Virus as a Function of the  Timing of Adoptive 
Transfer of Donor Lymphocytes Induced by Homologous Virus.  The data presented in Table 
III clearly show that splenocytes from mice infected with either aggressive or docile 
virus caused convulsive death in CY-treated recipients infected with heterotypic virus 
no more than 4  d  before adoptive transfer.  Because these experiments also showed 
that mice infected with docile virus could be suitable donors as well as recipients, it 
seemed logical to assume that mice infected with docile virus (in the absence of CY) 
might be killed by their own lymphocyte response to the infection if the timing of the 
interaction between virus and the immune system was appropriate. Table IV shows 
that  this is indeed the case. Virtually all mice infected i.c.  with docile virus for no 
more  than  3  d  developed CNS  disease  after receiving Thy-l-bearing lymphocyte 
populations taken from identical mice infected for 7 d. Although adoptive transfers in 
recipient mice infected for 4 d resulted in three- to fourfold more deaths than expected 
from  the  i.e.  infection alone,  no convulsive death  pattern  was  observed. Adoptive 
transfer on the 7th d after infection of the recipients clearly had no effect. 
Multiplication  and Distribution of Viruses.  Because we had previously established (10, 
11) that docile virus replication commenced more quickly and reached higher titers 
in the brain than aggressive virus, the patterns of replication were established in other 
organs. At 24-h intervals for 7 d after i.c. infection with 300 PFU of either aggressive 
or docile substrains, virus contents in the brain, heart, kidneys, liver, lungs, and spleen 
were determined by plaque titration. As shown in Fig.  1, the patterns of replication 
established in the brain were generally observed in other organs. The responses could 
be roughly categorized into three groups. In the first group  (lung and liver), docile 
virus was easily detected by the 2nd d  after infection, whereas aggressive virus was 
not seen until the 4th to 6th d. At all times aggressive virus titers lagged behind docile 
virus  1-4 log units.  In  the second  group  (spleen  and  brain),  both  virus  substrains i0  e 
Days recipi- 
ents in-  LCM-like 
fected be-  Number of  Percent  Days to death in re-  convulsive 
fore adop-  mice  mortality  cipient mice (range)  death 
tive transfer 
0  8  100  7.0 (6--9)  + 
1  15  100  7.2 (6-9)  + 
2  16  88  7.3 (6-9)  + 
3  28  93  7.5  (5-13)  + 
3*  8  0  --  - 
4  19  58  12.4 (6-22)  - 
7  30  23  11.9 (4-17)  - 
The protocol was exactly as given in Table III except for the exclusive use of 
C3H mice as both donors and recipients. All splenocytes used for the adoptive 
transfer  were  taken  from  mice  on  the  7th  d  after  infection.  Data  were 
compiled based on injection of no less than five recipient mice per group. 
* Lymphocytes treated with Thy-1 antibody and complement. 
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TABLE IV 
Correlation between Day of Adoptive Transfer and Ability  to Kill Mice 
Infected with Docile Virus 
DOCILE  STRAll 
B  AGGRESSIVE S 
RANGE 
84 
DAYS AFTER  INFECTION 
FIG.  1.  C3H mice were injected i.c. with 300 PFU of either aggressive or docile LCM substrain. At 
24-h intervals for 7 d, two mice (occasionally one) in each group were killed.  Each of the organs was 
separately weighed and titrated by plaque assay. These data were combined with the results of four 
other experiments in which specific organs were titrated on various days after infection. Thus, the 
average titers were usually based on three to four individual titrations and sometimes as many as 
six. When no range is given, there was only one titration. PFAU ET AL.  85 
could be detected at the same time, either on the 1st or 2nd day after infection. Again, 
aggressive virus titers usually lagged behind docile virus by 1-4 log units of infectivity. 
The  highest  titers were  generally encountered  in  the spleens of mice  infected with 
docile virus (in one case reaching 2  ×  10 l° PFU/g  on the 4th day after infection). In 
the third group (kidney and heart), little, if any, virus of either type could be detected 
until the 4th or 5th day after infection. Because this time interval coincided with the 
detection of virus  in  the  blood, these organs  may  not  have  been  truly  infected.  It 
should be pointed out that differences in the content of aggressive and docile viruses 
in the visceral organs would have been larger by ~  100-fold if titrations were carried 
out using LDs0 assays (1  LDs0 =  ~  10  PFU of aggressive strain but only 0.1  PFU of 
docile strain, as indicated in Table I). 
Aggressive Virus Replication, Distribution, and Pathogenicity in Mice as a Function of  Inoculum 
Size.  The data in Fig. 1 and Table I, taken together, indicated an inverse correlation 
between spread of the virus infection and lethality. With identical 300-PFU inoculum 
doses the rapidly spreading docile virus was not lethal, whereas the slowly disseminated 
aggressive virus killed. Because very high inocula of aggressive virus, unlike low doses, 
did not  kill  (Table  I), we  determined  whether  this same  inverse correlation would 
hold in this case as well. The data in Table V  clearly indicated that on the 3rd and 
4th day after infection, the sparing dose of aggressive virus resulted in very high titers 
of virus in all organs examined; higher than those caused by docile virus (Fig.  1). 
The  Time of Adoptive  Transfers that  Induce CNS Disease Varies with the Concentration of 
Docile  Virus Used to Infect Recipient Mice.  The previous results  (Table V  and  Fig.  1) 
showed  a  correlation  between  rapid  virus  spread  (whether  docile  or  aggressive 
substrains) and relatively benign infection. Suggestive of this correlation was the fact 
that increasing death rates were observed in mice infected with decreasing amounts 
of docile virus (Table I). Thus, mice were infected with either 30 or 300 PFU of docile 
virus (the former concentration causing four times the death rate as the latter). On 
TABLE V 
Virus Replication in Mice Infected i.c. with High and Low Doses of 
Aggressive Virus 
3 d post-infection (inoculum  4 d post-infection (inoculum 
[PFU/mouse])  [PFU/mouse]) 
300  1.5 ×  106  300  1.5 x  106 
Organ  Titers 
PFU/g 
Liver  <102  6.9 ×  104  <102  2.9 ×  107 
Lung  1.7 x  102  7.5 X 106  9.0 X l0  s  1.6 X 10  s 
Spleen  2.2 X 105  >4.8 ×  10  s  3.9 ×  10  e  >3.5 ×  l0  s 
Brain  5.8 x  103  3.2 X 105  3.8 X 104  1.8 ×  106 
Kidney  <102  9.4 ×  102  <102  3.7 ×  106 
Heart  <10 2  <10 2  <10 2  1.5 X 105 
Serum  <102  2.0 ×  10  a  <102  1.8 ×  105 
10 C3H  mice were divided equally into two groups; one injected  with 300 
PFU/mouse, and the other with 1.5 ×  10  e PFU/mouse. On the 3rd and 4th d 
after infection, one mouse from each group was bled and killed. The three 
remaining mice in each group were observed daily. All mice receiving the low 
dose of virus died on day 9, whereas all mice receiving the high dose were 
healthy on the 28th d after infection, when the experiment was terminated. 86  LYMPHOCYTIC  CHORIOMENINGITIS  VIRUS  KILLER  T  CELLS 
TABLE  VI 
The Interrelationship between Virus Inoculum Size, Spread of the Infection, and Loss 
of Susceptibility to Being Killed by Adoptive Transfer 
Days recipi- 
ents infected  Infection  Number of  Percent  Days to death in re- 
before adop-  dose  mice  mortality  cipient mice (range) 
tive transfer 
PFU/reczpient 
3  300  5  100  7.4 (6-10) 
4  300  5  40  12.5  (7-18) 
4  30  5  100  7.2 (5-10) 
5  30  5  100  7.6 (4-10) 
Protocol was exactly as described in Table IV. 
the  4th  day after infection  (this  day being chosen  because  mice infected with  300 
PFU of docile virus could no longer be killed by adoptive transfer;  Table IV) virus 
content  of liver, lungs, and spleen were determined.  In each case the organ titers of 
mice infected with 30 PFU of virus were <300 PFU inoculum (PFU/g: liver, <102 vs. 
8 ×  103; lung, 6 ×  103 vs.  1.2  ×  10P; spleen,  1.7  ×  108 vs. 2.0 ×  101°), with the day-4 
30-PFU inoculum yields falling within the  range of virus titers expected on day 3 for 
the 300-PFU inoculum (Fig.  1). This led to  the prediction and the finding (Table VI) 
that mice infected with 30 PFU of docile virus could be killed by adoptive transfer 
later (by at least 2 d) than mice infected with 300 PFU of virus. 
Discussion 
The adoptive transfer experiments presented here clearly indicate that an insuffi- 
cient T  cell response is unlikely to be the reason why adult mice live after i.c. infection 
with a given strain of LCM virus. Before these studies the possibility existed that the 
strong CTL response observed in our docile virus-infected mice (11) did not necessarily 
represent a  population of effector cells capable of causing CNS disease. On the other 
hand,  although  the  CTL  responses  induced  by  docile  or  aggressive  viruses  were 
comparable  against  those  induced  by  target  L  cells  infected  with  homologous  or 
heterotypic  virus,  we  proposed  that  their  inability  to  kill  in  vivo could  be  due  to 
"target  defects" in  mice infected with  docile  virus  (11).  The target organ  has been 
assumed to be the brain because of the infiltration  of lymphocytes and macrophages 
in the virus-infected choroid plexus, ependyma, and  meninges. Although  there is no 
rigorous  proof for this,  meningeal  inflammatory  exudate  may be isolated  from the 
cisterna magna and constitutes a potent source of LCM-specific cytotoxic T  cells (22). 
The data presented in this paper raise the possibility  that these defects may be in the 
abundance rather than in the lack of target cells and  organs for virus-specifi~ T  cells. 
What we can say definitely is that a strong inverse  correlation exists between lethality 
and spread of the  infection.  This was shown  in  a  number of ways:  (a)  Only when 
docile virus dissemination and replication was at an  early stage in recipient mice was 
it possible to induce CNS disease by adoptive  transfer (Tables III, IV, and VI).  (b) 
Only  very high  i.c.  doses  of aggressive virus,  which  mimicked  the  normally  rapid 
spread of docile virus (Fig.  1 and Table V),  were not lethal.  (c) Only very low doses 
of docile virus, which mimicked the normally  slow spread of aggressive virus  (Table 
I), were highly lethal. 
The hypothesis that disease outcome in mice is determined by the number of target PFAU ET AL.  87 
organs "seen" by the T  cell response against LCM infection, has received increasing 
attention over the last  10 yr. It was first advanced by Gilden and colleagues (6)  in 
their classic studies  using adoptive transfers to show the central  role of T  cells  in 
inducing  CNS  disease  in  mice.  They  noted  that  such  passive  immunization  in 
neonatally infected adult carrier mice, while suppressing viremia and inducing high 
levels of CF antibodies (23), failed to cause CNS disease. They suggested that because 
neonate  carrier  mice  had  more  widespread  tissue  infection  with  higher  levels  of 
viremia than  CY carriers, immune lymphoid cells would be diverted so that  fewer 
reached  the  choroid  plexus.  Consistent  with  this  view  was  their  finding  of the 
importance of the timing of adoptive transfer in CY-spared mice (6). Whereas  100% 
mortality was obtained when adoptive transfer was carried out 5-9 d after infection, 
the severity of choroiditis was much lower, survival time longer, and mortality lower 
when drug-induced carriers were given cells a  month or more after infection when 
viremia was always present. Thomsen and colleagues (20) also noted the loss of the 
ability of adoptive transfers to kill when delayed for too long. They suggested that 
immunosuppression allowed the infection to spread to many organs so that the brain 
was no longer the main target for the immune attack. These views were also expressed 
by Zinkernagel and Doherty (24), who further stated that focusing the immune attack 
on  the  brain  could  also  be  the  explanation  why  i.c.  infection  with  low  doses  of 
viscerotropic virus (defined as a strain that grew widely in the body) were fatal. They 
pointed out that this postulate was based on the assumption that a maximal cytotoxic 
T  cell response is made regardless of the strain of virus used. 
Our  data  showing  that  rapid  spread  of an  LCM  infection  assures  survival  is 
consistent  with,  and  lends  further support  to  the  hypothesis  that  multiple  target 
organs divert the focused assault of virus-specific T  cells on the brain. The next step 
in  testing this hypothesis is  to find where CTL are at  various stages of lethal  and 
nonlethal  LCM  infections. Preliminary results in our laboratory already show that 
CTL activity in the lungs of mice infected with docile virus is much higher than when 
agressive virus is used. Supportive evidence also comes from recent data, published by 
Lehmann-Grube and colleagues (25), using a strain of LCM virus (WE) showing i.e. 
high  virus  dose survival  in  CBA/J  mice.  They found that  CTL recoverable from 
spleens were markedly fewer when mice were injected (i.v.) with 10 7, rather than  102, 
infectious U  of virus.  Although  the conclusion was  made that  the high  virus dose 
suppressed cell-mediated immunity, an alternate explanation is that  the high virus 
dose established multiple target organs very quickly with a concomitant recruitment 
of virus-specific lymphocytes from the spleen. 
Because the greater part of an intracerebral inoculum spills over immediately into 
the blood stream (26), and because both strains of LCM show no great difference in 
growth  rate  in  tissue  culture  (27),  it  is  not  clear  why  aggressive  virus  lags  so 
dramatically behind  docile virus  in  its  appearance  and  replication  in  the  visceral 
organs.  We  have  considered  the  role  of interferon  here.  Its  central,  but  as  yet 
undefined, importance in the adult LCM infection can be shown by comparing the 
docile and  aggressive virus infections. On  the one hand,  mice infected with  docile 
virus  will  develop  CNS  disease  with  appropriately  timed  injections  of interferon 
inducers  (10). On  the other hand,  adult  mice infected with aggressive virus strains 
will  be spared by treatment  with anti-interferon serum  (28;  C. J.  Pfau  and  K.  D. 
Hunt, unpublished observations). This sparing is accompanied by a  100- to 1000-fold 88  LYMPHOCYTIC CHORIOMENINGITIS  VIRUS  KILLER T  CELLS 
rise in viremia (28;  Pfau and Hunt, see above), and we are currently determining the 
kinetics of spread of the aggressive virus under these conditions.  Continued  investi- 
gations of the interplay between  interferon,  virus spread, and the immune response 
may be important in understanding  how human disorders could be caused by virus 
tropisms and immunological recognition of infected targets. 
Summary 
Two  types  of lymphocytic choriomeningitis  (LCM)  viruses  were  studied  which, 
upon  intraeerebral  injection  into  adult  C3H  mice,  provoked either  (a)  acute  fatal 
central nervous system (CNS)  disease or (b)  life-long persistent  infection.  Both virus 
types, (a) aggressive and (b)  docile, had been found to induce LCM-specific lympho- 
cytes with comparable in vitro lytic activity (11).  Because the requirement for T  cells 
in  the  development  of adult  LCM  disease  has  been  extensively  documented,  we 
sought other reasons for the lack of acute disease in mice infected with docile virus. A 
striking correlation  was  found between  the outcome of the  infection  and  spread of 
virus  to  visceral organs.  Adoptive  transfer  experiments  showed  that  a  300-plaque- 
forming unit inoculum of docile virus induced a  population of T  cells in donor mice 
fully capable of causing CNS disease in identically infected recipients.  This disease- 
causing ability was lost if the interaction was delayed beyond 3 d after infection of the 
recipients, but could be preserved by lowering the size of the viral inoculum  in  the 
recipients.  Furthermore,  without  adoptive  transfer,  very low  intracerebral  doses of 
docile  virus  (which  mimicked  the  normally  slow  spread  of aggressive  virus)  were 
lethal.  On the other hand,  very high doses of aggressive virus, which  mimicked the 
normally rapid spread of docile virus, did not induce fatal CNS disease. The results 
suggest that rapid dissemination of the LCM infection creates multiple target organs 
which divert the focused lethal T  cell attack on the brain. 
Received  for publication 8 February 1982 and in revised  form  1 April 1982. 
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